Mimura K - Search Results

1

Current status of cancer immunotherapy for esophageal squamous cell carcinoma.

Kono K, Mimura K, Yamada R, Ujiie D, Hayase S, Tada T, Hanayama H, Min AKT, Shibata M, Momma T, Saze Z, Ohki S. Kono K, et al. Among authors: mimura k. Esophagus. 2018 Jan;15(1):1-9. doi: 10.1007/s10388-017-0596-2. Epub 2017 Nov 27. Esophagus. 2018. PMID: 29892809 Review.

2

[Generation of HER2 specific, HLA-A24 restricted CTLs derived from gastric cancer patients].

Mimura K, Kono K, Sugai H, Miyagawa N, Omata H, Fujii H, Matsumoto Y. Mimura K, et al. Gan To Kagaku Ryoho. 2003 Oct;30(11):1802-4. Gan To Kagaku Ryoho. 2003. PMID: 14619524 Japanese.

3

Trastuzumab (Herceptin) enhances class I-restricted antigen presentation recognized by HER-2/neu-specific T cytotoxic lymphocytes.

Kono K, Sato E, Naganuma H, Takahashi A, Mimura K, Nukui H, Fujii H. Kono K, et al. Among authors: mimura k. Clin Cancer Res. 2004 Apr 1;10(7):2538-44. doi: 10.1158/1078-0432.ccr-03-0424. Clin Cancer Res. 2004. PMID: 15073134

4

[Generation of HER2 specific, HLA-A24 restricted CTLs derived from a healthy donor].

Mimura K, Kono K, Miyagawa N, Omata H, Sugai H, Fujii H. Mimura K, et al. Gan To Kagaku Ryoho. 2004 Oct;31(11):1795-6. Gan To Kagaku Ryoho. 2004. PMID: 15553718 Japanese.

5

Trastuzumab-mediated antibody-dependent cellular cytotoxicity against esophageal squamous cell carcinoma.

Mimura K, Kono K, Hanawa M, Kanzaki M, Nakao A, Ooi A, Fujii H. Mimura K, et al. Clin Cancer Res. 2005 Jul 1;11(13):4898-904. doi: 10.1158/1078-0432.CCR-04-2476. Clin Cancer Res. 2005. PMID: 16000588

6

A newly identified MAGE-3-derived, HLA-A24-restricted peptide is naturally processed and presented as a CTL epitope on MAGE-3-expressing gastrointestinal cancer cells.

Miyagawa N, Kono K, Mimura K, Omata H, Sugai H, Fujii H. Miyagawa N, et al. Among authors: mimura k. Oncology. 2006;70(1):54-62. doi: 10.1159/000091185. Epub 2006 Jan 27. Oncology. 2006. PMID: 16446550

7

Vascular endothelial growth factor inhibits the function of human mature dendritic cells mediated by VEGF receptor-2.

Mimura K, Kono K, Takahashi A, Kawaguchi Y, Fujii H. Mimura K, et al. Cancer Immunol Immunother. 2007 Jun;56(6):761-70. doi: 10.1007/s00262-006-0234-7. Epub 2006 Nov 4. Cancer Immunol Immunother. 2007. PMID: 17086423 Free PMC article.

8

Cetuximab induce antibody-dependent cellular cytotoxicity against EGFR-expressing esophageal squamous cell carcinoma.

Kawaguchi Y, Kono K, Mimura K, Sugai H, Akaike H, Fujii H. Kawaguchi Y, et al. Among authors: mimura k. Int J Cancer. 2007 Feb 15;120(4):781-7. doi: 10.1002/ijc.22370. Int J Cancer. 2007. PMID: 17096332

9

Vascular endothelial growth factor partially inhibits the trastuzumab-mediated antibody-dependent cellular cytotoxicity of human monocytes.

Mimura K, Kono K, Takahashi A, Kawaguchi Y, Mizukami Y, Fujii H. Mimura K, et al. Oncology. 2007;72(3-4):172-80. doi: 10.1159/000112803. Epub 2007 Dec 20. Oncology. 2007. PMID: 18097168

10

Protein-bound polysaccharide K partially prevents apoptosis of circulating T cells induced by anti-cancer drug S-1 in patients with gastric cancer.

Kono K, Kawaguchi Y, Mizukami Y, Mimura K, Sugai H, Akaike H, Fujii H. Kono K, et al. Among authors: mimura k. Oncology. 2008;74(3-4):143-9. doi: 10.1159/000151361. Epub 2008 Aug 18. Oncology. 2008. PMID: 18708731 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

581 results

Search Page

Filters